KLRC2 and B-cell chronic lymphocytic leukemia: A decrease in NKG2A was observed in the CTL from CLL subjects (2.42 ± 0.35 vs. 7.63 ± 2.11 in healthy controls; p < 0.005), while no difference was revealed in NKG2C expression (Figure 12A).